GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Net Issuance of Debt

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Net Issuance of Debt : $0.00 Mil (TTM As of Dec. 2022)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. CERo Therapeutics Holdings's net issuance of debt for the six months ended in Dec. 2022 was $0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

CERo Therapeutics Holdings Net Issuance of Debt Historical Data

The historical data trend for CERo Therapeutics Holdings's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Net Issuance of Debt Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Net Issuance of Debt
- -

CERo Therapeutics Holdings Semi-Annual Data
Dec21 Dec22
Net Issuance of Debt - -

CERo Therapeutics Holdings Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CERo Therapeutics Holdings Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Net Issuance of Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080
Website
https://www.cero.bio
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024